The peak of anion gap during the first 24h predicts 30day mortality in ACS patients who underwent primary percutaneous coronary intervention under extracorporeal membrane oxygenation.
Elevated microRNA-499 level in early phase of non-ST elevation acute coronary syndromes predicts increased long-term risk of major adverse cardiac events.